نتایج جستجو برای: renoprotection

تعداد نتایج: 483  

2013
Hamid Nasri Ali Ghorbani

*Corresponding author: Ali Ghorbani, Department of Nephrology, Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. E-mail: [email protected] Implication for health policy/practice/research/medical education: The initiation of erythropoietin therapy for the purpose of renoprotection may need to be sooner than that for erythropoiesis, because erythropoietin may...

Journal: :Kidney international 2003
Mauro Abbate Giuseppe Remuzzi

Glomerulopathies due to defective known genes are partially or completely reversed at 24 months without becoming a central source of information in the field clear change in creatinine clearance. Other reports deof mechanisms of progression of renal disease. Among scribed no effects of ACE inhibitor in few sporadic cases. hereditary diseases, Alport syndrome of glomerulopathy In this issue of K...

Journal: :Circulation 2002
Lionel H Opie Hans-Henrik Parving

Recent years have seen the seemingly unstoppable attack by cardiologists on all diseases that limit cardiovascular health. Nowhere is this more evident than in the case of diabetes mellitus, the subject of an important article in this issue of Circulation1 that relates to renoprotection in type 2 diabetes mellitus. As a background, type 2 diabetes is increasing in incidence and cardiological si...

2014
Mohd Urooj Monika Tandon Sunil S. Iyer

Hypertension is a common cause of chronic kidney disease (CKD) and even more common sequelae of CKD. It is essential to preserve renal function while controlling blood pressure. There is growing evidence that reduction and normalization of proteinuria is a key treatment goal for renal protection. Several clinical studies, mainly but not exclusively in diabetic patients were reviewed, subsequent...

Journal: :Journal of the American Society of Nephrology : JASN 2002
Liffert Vogt Gerjan Navis Dick de Zeeuw

Data from recent clinical trials show that lowering of BP reduces the rate of renal function loss in chronic renal disease. There is evidence supporting the assertion that BP lowering obtained by intervention in the renin-angiotensin-aldosterone system (RAAS) has an additive renoprotective effect in both diabetic and nondiabetic renal diseases. However, to dissociate BP-dependent and non-BP-dep...

2014
Mehri Kadkhodaee Zahra Sedaghat

*Corresponding author: Prof. Mehri Kadkhodaee, Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. E-mail: [email protected] Implication for health policy/practice/research/medical education: The possibility to create resistance against ischemic injury through ‘organ conditioning’ is an area of increasing interest. The remote ischemic condit...

2017
Youling Fan Hongtao Chen Huihua Peng Fang Huang Jiying Zhong Jun Zhou

As a highly perfused organ, the kidney is especially sensitive to ischemia and reperfusion. Ischemia-reperfusion (IR)-induced acute kidney injury (AKI) has a high incidence during the perioperative period in the clinic and is an important link in ischemic acute renal failure (IARF). Therefore, IR-induced AKI has important clinical significance and it is necessary to explore to develop drugs to ...

2014
Ki Heon Nam Jeong Hae Kie Mi Jung Lee Tae-Ik Chang Ea Wha Kang Dong Wook Kim Beom Jin Lim Jung Tak Park Young Eun Kwon Yung Ly Kim Kyoung Sook Park Seong Yeong An Hyung Jung Oh Tae-Hyun Yoo Shin-Wook Kang Kyu Hun Choi Hyeon Joo Jeong Dae-Suk Han Seung Hyeok Han

BACKGROUND Proteinuria is a target for renoprotection in kidney diseases. However, optimal level of proteinuria reduction in IgA nephropathy (IgAN) is unknown. METHODS We conducted a retrospective observational study in 500 patients with biopsy-proven IgAN. Time-averaged proteinuria (TA-P) was calculated as the mean of every 6 month period of measurements of spot urine protein-to-creatinine r...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید